Perioperative beta-adrenoblocker therapy and cardiovascular event risk: are all the problems solved?
The paper focuses on beta-blocker potential in perioperative period among the patients undergoing non-cardiac surgery. The results of two randomised clinical trials, POISE (2007) and DECREASE (1999-2009), are analysed.
Main Author: | Yu. M. Lopatin |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«SILICEA-POLIGRAF» LLC
2009-12-01
|
Series: | Кардиоваскулярная терапия и профилактика |
Subjects: | |
Online Access: | https://cardiovascular.elpub.ru/jour/article/view/1516 |
Similar Items
-
Beta-adrenoblocker in heart failure: bisoprolol role
by: Yu. V. Lukina, et al.
Published: (1970-01-01) -
Beta-adrenoblockers in clinical practice: is there any difference?
by: D. V. Nebieridze, et al.
Published: (2007-06-01) -
Cardioselective beta-adrenoblocker bisoprolol in treating hypertensive patients with heart failure
by: A. N. Britov
Published: (2005-06-01) -
Differential beta-adrenoblocker therapy in chronic heart failure
by: S. N. Tereshchenko, et al.
Published: (1970-01-01) -
Beta-adrenoblockers in coronary heart disease patients. Evidencebased medicine data
by: A. E. Radzevich, et al.
Published: (1970-01-01)